IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance
- PMID: 12594294
- DOI: 10.4049/jimmunol.170.5.2655
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance
Abstract
IL-17 is a T cell-derived proinflammatory cytokine in experimental arthritis and is a stimulator of osteoclastogenesis in vitro. In this study, we report the effects of IL-17 overexpression (AdIL-17) in the knee joint of type II collagen-immunized mice on bone erosion and synovial receptor activator of NF-kappa B ligand (RANKL)/receptor activator of NF-kappa B/osteoprotegerin (OPG) expression. Local IL-17 promoted osteoclastic bone destruction, which was accompanied with marked tartrate-resistant acid phosphatase activity at sites of bone erosion in cortical, subchondral, and trabecular bone. Accelerated expression of RANKL and its receptor, receptor activator of NF-kappa B, was found in the synovial infiltrate and at sites of focal bone erosion, using specific immunohistochemistry. Interestingly, AdIL-17 not only enhanced RANKL expression but also strongly up-regulated the RANKL/OPG ratio in the synovium. Comparison of arthritic mice from the AdIL-17 collagen-induced arthritis group with full-blown collagen-arthritic mice having similar clinical scores for joint inflammation revealed lower RANKL/OPG ratio and tartrate-resistant acid phosphatase activity in the latter group. Interestingly, systemic OPG treatment prevented joint damage induced by local AdIL-17 gene transfer in type II collagen-immunized mice. These findings suggest T cell IL-17 to be an important inducer of RANKL expression leading to loss of the RANKL/OPG balance, stimulating osteoclastogenesis and bone erosion in arthritis.
Similar articles
-
Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.Arthritis Rheum. 2002 Nov;46(11):3055-64. doi: 10.1002/art.10607. Arthritis Rheum. 2002. PMID: 12428250
-
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion.J Clin Invest. 2000 Jun;105(12):1697-710. doi: 10.1172/JCI7739. J Clin Invest. 2000. PMID: 10862785 Free PMC article.
-
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.J Immunol. 2002 Sep 15;169(6):3353-62. doi: 10.4049/jimmunol.169.6.3353. J Immunol. 2002. PMID: 12218157
-
Bone destruction in arthritis.Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii84-6. doi: 10.1136/ard.61.suppl_2.ii84. Ann Rheum Dis. 2002. PMID: 12379632 Free PMC article. Review.
-
RANK, RANKL and osteoprotegerin in arthritic bone loss.Braz J Med Biol Res. 2005 Feb;38(2):161-70. doi: 10.1590/s0100-879x2005000200004. Epub 2005 Feb 15. Braz J Med Biol Res. 2005. PMID: 15785827 Review.
Cited by
-
Cytokine-mediated immunomodulation of osteoclastogenesis.Bone. 2022 Nov;164:116540. doi: 10.1016/j.bone.2022.116540. Epub 2022 Aug 27. Bone. 2022. PMID: 36031187 Free PMC article. Review.
-
Molecular mechanisms and clinical management of cancer bone metastasis.Bone Res. 2020 Jul 29;8(1):30. doi: 10.1038/s41413-020-00105-1. eCollection 2020. Bone Res. 2020. PMID: 32793401 Free PMC article. Review.
-
Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis.Arthritis Res Ther. 2005;7(1):R139-48. doi: 10.1186/ar1470. Epub 2004 Nov 29. Arthritis Res Ther. 2005. PMID: 15642134 Free PMC article.
-
Interleukin 17A: a Janus-faced regulator of osteoporosis.Sci Rep. 2020 Mar 30;10(1):5692. doi: 10.1038/s41598-020-62562-2. Sci Rep. 2020. PMID: 32231224 Free PMC article.
-
Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.Rheum Dis Clin North Am. 2018 Feb;44(1):89-111. doi: 10.1016/j.rdc.2017.09.005. Rheum Dis Clin North Am. 2018. PMID: 29149929 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources